Depending on the stage, CKD can reduce not only renal 1α-hydroxylase and the amount of filtered 25(OH)D but also renal megalin content and the uptake of 25(OH)D by monocytes–macrophages, markedly impairing both endocrine and autocrine VDR activation (7, 8). The gene discussed is LRP2; the disease is chronic kidney disease.